CONSOLIDATED STATEMENTS OF OPERATIONS [Parenthetical] (USD $)
|
12 Months Ended | 77 Months Ended | |
---|---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2011
|
|
Stock-based compensation costs | $ 204,898 | $ 160,712 | $ 2,457,421 |
Research and development stock based costs | 982 | 67,222 | 465,034 |
Research and development stock based costs,related party | 25,000 | 17,708 | 42,708 |
Research and development, representing the proceeds of a government grant | $ 244,479 | $ 244,479 | $ 244,479 |
X | ||||||||||
- Definition
The amount of grant applied for and received under the Patient Protection and Affordable Care Act signed into law on March 23, 2010 and is based upon qualified investments made in 2009 and 2010. The amount is recorded as an offset to the qualified investments made. No definition available.
|
X | ||||||||||
- Definition
The aggregate amount of noncash, equity-based remuneration to employees and vendors, included in total research and development costs, related to research and development activities. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. No definition available.
|
X | ||||||||||
- Definition
The aggregate amount of noncash, equity-based remuneration to related party, included in the total amount of research and development stock based costs, related to research and development activities. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. No definition available.
|
X | ||||||||||
- Definition
The aggregate amount of noncash, equity-based remuneration to employees and vendors, included in total general and administrative costs, related to general and administrative activities. This may include the value of stock or unit options and amortization of restricted stock or units. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. No definition available.
|